News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
852,837 Results
Type
Article (86873)
Company Profile (704)
Press Release (765258)
Multimedia
Podcasts (145)
Webinars (19)
Section
Business (232815)
Career Advice (4132)
Deals (39763)
Drug Delivery (129)
Drug Development (91109)
Employer Resources (198)
FDA (18186)
Job Trends (17363)
News (396842)
Policy (39824)
Tag
Academia (3002)
Academic (2)
Accelerated approval (11)
Adcomms (32)
Allergies (106)
Alliances (56975)
ALS (119)
Alzheimer's disease (1567)
Antibody-drug conjugate (ADC) (187)
Approvals (18137)
Artificial intelligence (397)
Autoimmune disease (37)
Automation (18)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (135)
Biotechnology (481)
Bladder cancer (100)
Brain cancer (40)
Breast cancer (390)
Cancer (3080)
Cardiovascular disease (248)
Career advice (3540)
Career pathing (34)
CAR-T (209)
CDC (40)
Cell therapy (573)
Cervical cancer (24)
Clinical research (74305)
Collaboration (1108)
Company closure (3)
Compensation (711)
Complete response letters (33)
COVID-19 (2904)
CRISPR (67)
C-suite (353)
Cystic fibrosis (121)
Data (3081)
Decentralized trials (2)
Denatured (51)
Depression (76)
Diabetes (380)
Diagnostics (6979)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (181)
Drug pricing (152)
Drug shortages (36)
Duchenne muscular dystrophy (132)
Earnings (97510)
Editorial (48)
Employer branding (25)
Employer resources (169)
Events (131464)
Executive appointments (909)
FDA (19917)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1015)
Gene editing (147)
Generative AI (39)
Gene therapy (436)
GLP-1 (934)
Government (5260)
Grass and pollen (6)
Guidances (181)
Healthcare (20917)
HIV (8)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (184)
Immuno-oncology (10)
Indications (40)
Infectious disease (3101)
Inflammatory bowel disease (164)
Inflation Reduction Act (13)
Influenza (71)
Intellectual property (124)
Interviews (813)
IPO (17906)
IRA (55)
Job creations (5193)
Job search strategy (2863)
Kidney cancer (15)
Labor market (56)
Layoffs (590)
Leadership (26)
Legal (10137)
Liver cancer (85)
Lung cancer (432)
Lymphoma (215)
Machine learning (11)
Management (65)
Manufacturing (443)
MASH (99)
Medical device (14728)
Medtech (14733)
Mergers & acquisitions (22578)
Metabolic disorders (966)
Multiple sclerosis (104)
NASH (23)
Neurodegenerative disease (142)
Neuropsychiatric disorders (42)
Neuroscience (2322)
NextGen: Class of 2025 (7687)
Non-profit (5090)
Now hiring (48)
Obesity (495)
Opinion (290)
Ovarian cancer (104)
Pain (120)
Pancreatic cancer (125)
Parkinson's disease (201)
Partnered (25)
Patents (317)
Patient recruitment (170)
Peanut (55)
People (65715)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22935)
Phase II (32262)
Phase III (24295)
Pipeline (1692)
Policy (241)
Postmarket research (3552)
Preclinical (10357)
Press Release (72)
Prostate cancer (149)
Psychedelics (45)
Radiopharmaceuticals (279)
Rare diseases (524)
Real estate (7402)
Recruiting (76)
Regulatory (27170)
Reports (61)
Research institute (2666)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (10)
RSV (58)
Schizophrenia (98)
Series A (172)
Series B (118)
Service/supplier (30)
Sickle cell disease (67)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (37)
Startups (4304)
State (2)
Stomach cancer (17)
Supply chain (84)
Tariffs (65)
The Weekly (92)
Vaccines (917)
Venture capital (57)
Weight loss (331)
Women's health (52)
Worklife (20)
Date
Today (80)
Last 7 days (426)
Last 30 days (2079)
Last 365 days (34055)
2025 (18376)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1273)
Alabama (70)
Alaska (7)
Arizona (280)
Arkansas (14)
Asia (50531)
Australia (8878)
California (7784)
Canada (2412)
China (725)
Colorado (340)
Connecticut (348)
Delaware (205)
Europe (115934)
Florida (1154)
Georgia (263)
Hawaii (2)
Idaho (66)
Illinois (741)
India (32)
Indiana (386)
Iowa (18)
Japan (237)
Kansas (115)
Kentucky (33)
Louisiana (18)
Maine (73)
Maryland (1101)
Massachusetts (5954)
Michigan (276)
Minnesota (484)
Mississippi (3)
Missouri (100)
Montana (32)
Nebraska (26)
Nevada (82)
New Hampshire (73)
New Jersey (2181)
New Mexico (31)
New York (2184)
North Carolina (1245)
North Dakota (10)
Northern California (3353)
Ohio (251)
Oklahoma (17)
Oregon (48)
Pennsylvania (1660)
Puerto Rico (18)
Rhode Island (39)
South America (1654)
South Carolina (36)
South Dakota (1)
Southern California (2880)
Tennessee (129)
Texas (1191)
United States (29384)
Utah (230)
Virginia (212)
Washington D.C. (80)
Washington State (687)
West Virginia (4)
Wisconsin (86)
There are 852,837 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Infectious disease
Gilead, GSK/ViiV, Merck Present New HIV PrEP Frontiers at IAS25
HIV pharma leaders are at Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the heels of the landmark Yeztugo approval.
July 15, 2025
·
4 min read
·
Tristan Manalac
Policy
FDA Commissioner Marty Makary Proposes Lowering Industry User Fees
According to Makary, reducing user fees—which make up just under half of the FDA’s budget—could
make it easier for smaller companies, individual investors and academics to participate in the process.
July 15, 2025
·
2 min read
·
Tristan Manalac
Obesity
Hengrui’s Dual GLP-1/GIP Elicits 17.7% Weight Loss in Phase III
The molecule, developed in collaboration with Massachusetts-based Kailera Therapeutics, is headed for a new drug application in China and global clinical trials.
July 15, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Alzheon to Present Insights into Oral Valiltramiprosate/ALZ-801 Mode of Action and Clinical Efficacy at Dedicated Symposium at Alzheimer’s Association International Conference in Toronto on July 30th, 2025
July 15, 2025
·
12 min read
Press Releases
Cantargia Announces the Acquisition of its CAN10 IL1RAP Immunology Program by Otsuka Pharmaceutical
July 15, 2025
·
4 min read
Press Releases
Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors
July 15, 2025
·
3 min read
Press Releases
AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Disease
July 15, 2025
·
4 min read
Press Releases
Argon Medical Streamlines Distribution of Product and Enhances Customer Training for Europe, Asia, and Africa with the Debut of a Modern, Mixed-Use Facility
July 15, 2025
·
2 min read
Press Releases
4TEEN4 Announces Publication in European Journal of Heart Failure Demonstrating First-in-Human Shock Reversal Evidence for Procizumab in Three Compassionate Use Cases
July 15, 2025
·
5 min read
Press Releases
Oncomatryx Biopharma Awarded €12.5 Million EIC Accelerator Funding to Advance Groundbreaking ADCs
July 15, 2025
·
2 min read
1 of 85,284
Next
